Moderate to Severe Asthma Perspective

 
 

  • Asthma Highlights From ACAAI 2021   From ACAAI 2021, Dr Sandhya Khurana reports on advances in asthma, including novel biologic therapies, burden of corticosteroid use, and racial differences in late effects of COVID-19.
  • Air Supply: Targeting Eosinophils in Severe Asthma: Throwing up Roadblocks   Clinicians discuss the use of monoclonal antibodies in eosinophilic asthma, their benefits and drawbacks, and the importance of ongoing patient education.
  • Top Asthma Findings From CHEST 2021   From CHEST 2021, Dr Mario Castro reports on advances in asthma, including efficacy of a novel biologic therapy, improved outcomes with dupilumab, and data on the effect of cannabis in asthma patients.
  • Air Supply: Targeting Eosinophils in Severe Asthma: Life on Steroids   Leading pulmonologists discuss the consequences of long-term steroid use in the treatment of severe asthma, and a patient describes the burden of such therapy.
  • Air Supply: Targeting Eosinophils in Severe Asthma: Airtight   Asthma specialists and a patient with severe eosinophilic asthma describe the pathophysiology and the experience of an acute exacerbation.
  • Air Supply: Targeting Eosinophils in Severe Asthma   Leading pulmonologists discuss how the identification of eosinophilic subtypes has led to improved asthma management and development of new therapies for patients with severe asthma.
  • Severe Asthma Highlights From AAAAI 2021   Dr Mario Castro reviews key studies on severe asthma presented at the virtual 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) meeting, including the phase 3 NAVIGATOR trial.
  • AAAAI 2021 Read clinically focused news coverage of key developments from AAAAI 2021
  • Big, Important Changes in Asthma Management Guidelines   Dr Neil Skolnik summarizes the most significant changes to asthma management guidelines.
  • Does Asthma Lead to Worse COVID-19 Outcomes? It seems intuitive that people with asthma are more likely to be infected with COVID-19 and have more severe disease. But is it true? Aaron Holley takes a look.
  • 'Not Where We Need to Be' for Treating Severe Asthma Among all forms of asthma, severe T2L asthma accounts for the lion's share of medical expenditures, yet effective diagnostic and treatment approaches remain elusive.
  • Severe Asthma Abstracts From 2020 AAAAI Annual Meeting   Dr Michael Wechsler reviews key abstracts relating to severe asthma. The abstracts were published online after AAAAI was canceled because of concern over COVID-19.
  • AAAAI 2020 Read clinically focused news coverage of key developments from AAAAI 2020
  • Exposing the Role of Psychosocial Stress on Asthma Aaron Holley, MD, calls for more attention to the role of behavioral health in the clinical practice of asthma.
  • Addressing Asthma Management: What Clinicians Told Us The Medscape/CHEST survey reveals differences in how pulmonologists and other clinicians manage patients with moderate to severe asthma.
  • AAAAI 2019 Read clinically focused news coverage of key developments from AAAAI 2019
  • Review of Biologics in Children With Severe Asthma Biologics are revolutionizing the management of moderate to severe asthma. A summary of currently approved biologics in addition to a few new medications that are still being evaluated.
  • Transitioning Adolescents With Asthma to Adult Care   Drs Mary Cataletto and Navitha Ramesh on how to ensure your adolescent patients with asthma don't get lost to follow up on the way to adult medical care.
  • Biology of Asthma and Biologics: A Primer Dr Aaron Holley provides a brief overview of asthma and the basics of biologic therapy that targets different levels of the asthmatic response.
  • Asthma Emergencies: A Guide to Treating Exacerbations   Drs Sidney Braman and Navitha Ramesh on what you need to do for potentially dangerous asthma attacks, from onset to discharge.